James Maton

Co-Partner in Charge – London
jmaton@cooley.com
Full contact info

No case is ever the same and I relish problem solving and strategy.

About James

James is co-partner in charge of the London office, heads Cooley’s versatile UK disputes practice and is a member of the firm’s compensation committee. He is a solicitor advocate and acts for companies in a broad range of commercial, contractual, privacy and product compliance disputes – whether resolved in court proceedings or arbitration – including defending group actions. James’ cases are often multijurisdictional, and his work is particularly focused on the technology and manufacturing sectors. He conducts and co-ordinates internal investigations, and he is experienced at helping companies manage and resolve the numerous legal and reputational challenges that unexpected crises can present. 

View full bio

Passions

Scuba diving

Being the chair of Junior School Governors

Experience

Beihai Biotech Signs Exclusive Licensing, Supply and Commercialization Agreement With Zydus

Beihai Biotech Signs Exclusive Licensing, Supply and Commercialization Agreement With Zydus

February 14, 2025

Cooley advised Beihai Biotech, an innovative biopharmaceutical company, on its exclusive licensing, supply and commercialization agreement with Zydus Lifesciences for BEIZRAY.

Read more

Related contacts

Yiming Liu
Partner in Charge – Shanghai, Shanghai
Bin Wang
Special Counsel, Palo Alto
Zack Gong
Associate, Shanghai
James Maton
Co-Partner in Charge – London, London

Related Practices & Industries

Life Sciences Corporate Partnering and Licensing
Life Sciences
Healthcare
Mergers and Acquisitions
Capital Markets
Asia
Commercial Litigation

General Catalyst Leads Helsings 209 Million Euro Series B Financing

General Catalyst Leads Helsings 209 Million Euro Series B Financing

September 14, 2023

Cooley advised General Catalyst Partners, a venture capital firm providing early-stage and growth equity investments, as the lead investor in Helsing’s 209 million euro Series B financing.

Read more

Related contacts

Eric Popp
Associate, Boston
Stephanie McFarland
Associate, New York
Caroline Hobson
Partner, London
Chris Coulter
Partner, London
Aaron Pomeroy
Partner, Colorado
David Fletcher
Partner, Washington, DC
James Maton
Co-Partner in Charge – London, London
Kevin King
Partner, Washington, DC
Matthew Smith
Partner, Boston
Christopher Kimball
Partner, Washington, DC
Christine Graham
Special Counsel, London
Annie Froehlich
Partner, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Grant Schweikert
Special Counsel, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Anna Caro
Associate, London
Marzia Di Candido
Associate, London
Juan Nascimbene
Associate, London
María Álvarez Requejo Heredero
Associate, Brussels
Rick Jantz
Associate, Santa Monica
Randwulf P. Singleton
Associate, Colorado
Jason Minio
Paralegal Specialist, Boston

Related Practices & Industries

Emerging Companies
Venture Capital
Antitrust and Competition
Tax
CFIUS
Government Contracts
Export Controls and Economic Sanctions
Foreign Direct Investment
Artificial Intelligence
Technology

Justin Bieber to Sell Music Rights to Hipgnosis Songs for $200 Million

Justin Bieber to Sell Music Rights to Hipgnosis Songs for $200 Million

February 2, 2023

Cooley advised Justin Bieber in a $200 million deal to sell his music rights to Blackstone-backed Hipgnosis Songs Capital.

Read more

Related contacts

Matt Hallinan
Partner, Santa Monica
Jason Savich
Partner, San Francisco
Edmond Lay
Partner, San Diego
Harry Calkin
Associate, London
Calvin Lee
Associate, New York
Stephanie Gentile
Partner, New York
Chris Coulter
Partner, London
Aaron Pomeroy
Partner, Colorado
James Maton
Co-Partner in Charge – London, London
Leo Spicer-Phelps
Partner, London
Juan Nascimbene
Associate, London
Matthew S. Scarano
Associate, San Diego
Ellie Seber
Partner, Santa Monica

Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II

Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II

December 9, 2021

Cooley advised Alvotech Holdings, a global biopharmaceutical company focused on the development and manufacturing of biosimilar medicines for patients worldwide, on its agreement to merge with special purpose acquisition company (SPAC) Oaktree Acquisition Corp. II. Lawyers Michal Berkner, Div Gupta, Nicolas Dumont and Jarrett Burks led the Cooley team advising Alvotech.

Read more

Related contacts

Div Gupta
Partner, New York
Wouter Deleersnyder
Associate, New York
Sonia Nath
Partner, Washington, DC
Phil Mitchell
Partner, New York
Aaron Pomeroy
Partner, Colorado
Barbara Mirza
Partner, Santa Monica
Stacey A. Bradford
Special Counsel, Washington, DC
Rick Jantz
Associate, Santa Monica
Stella Sarma
Partner, Brussels
Sharon Connaughton
Special Counsel, Washington, DC
Alexandria Ashour
Associate, San Diego
Chris Coulter
Partner, London
David Dalton
Associate, Santa Monica
Neelam Atwal
Associate, London
Chris Stack
Partner, London
Alan W. Tamarelli
Partner, New York
Karen Tsai
Special Counsel, Washington, DC
Wyatt Kernell
Associate, Colorado
Reid Hooper
Special Counsel, Washington, DC
Megan Browdie
Partner, Washington, DC
Sanya Sukduang
Partner, Washington, DC
Alessandra Murata
Partner, Palo Alto
Natasha Leskovsek
Of Counsel, Washington, DC
James Maton
Co-Partner in Charge – London, London
Shehzad Akram
Associate, London
Sarah Oliai
Associate, Washington, DC
Barbara Borden
Senior Counsel, San Diego
Nicola Squire
Partner, London
Peter Byrne
Partner, New York
Claire Keast-Butler
Co-Partner in Charge – London, London
Jill Simon
Senior Paralegal, New York
Xander Lee
Partner, Santa Monica
Calvin Lee
Associate, New York

Related Practices & Industries

Mergers and Acquisitions
Life Sciences
Life Sciences Corporate Partnering and Licensing
Antitrust and Competition
Capital Markets
Compensation and Benefits
Labor and Employment
Healthcare
Export Controls and Economic Sanctions
Government Contracts
Intellectual Property Litigation
Public Companies
Tax
Technology Transactions

UNCITRAL Arbitration Brought Under NAFTA Chapter 11

UNCITRAL Arbitration Brought Under NAFTA Chapter 11

August 6, 2021

Representing a claimant in a UNCITRAL arbitration brought under NAFTA Chapter 11 seeking compensation exceeding US$2 billion for the arbitrary denial of an environmental permit for a subsea phosphate dredging project

Related contacts

James Maton
Co-Partner in Charge – London, London
View more

Rankings and accolades

The Legal 500 UK: Leading individual – Public international law

The Legal 500 UK: Commercial litigation – Premium

The Legal 500 UK: Crime, fraud and licensing

The Legal 500 UK: Dispute resolution

Chambers UK: Public International Law

Who’s Who Legal Asset Recovery: Lawyers

Described as ‘diligent’, ‘intelligent’ and ‘unflappable.’

UK Legal 500